The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism.
about
The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The NQO1 bioactivatable drug, ...... in central carbon metabolism.
@en
The NQO1 bioactivatable drug, ...... in central carbon metabolism.
@nl
type
label
The NQO1 bioactivatable drug, ...... in central carbon metabolism.
@en
The NQO1 bioactivatable drug, ...... in central carbon metabolism.
@nl
prefLabel
The NQO1 bioactivatable drug, ...... in central carbon metabolism.
@en
The NQO1 bioactivatable drug, ...... in central carbon metabolism.
@nl
P2093
P2860
P356
P1476
The NQO1 bioactivatable drug, ...... in central carbon metabolism.
@en
P2093
David A Boothman
Jessica Sudderth
Matthew E Merritt
Molly A Silvers
Muhammad S Beg
Ralph J DeBerardinis
Robert A Egnatchik
Shawn C Burgess
Xiuquan Luo
P2860
P304
18203-18216
P356
10.1074/JBC.M117.813923
P407
P577
2017-09-15T00:00:00Z